Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance

International Journal of Cancer. Journal International Du Cancer
Anamaria BrozovicB Kaina

Abstract

Tumor cells chronically exposed to cisplatin (cDDP) acquire cDDP resistance that impacts tumor therapy. To elucidate the mechanism of acquired cDDP resistance (ACR), we compared HeLa cells that gained ACR upon chronic cDDP treatment with the parental strain. We show that ACR is due to a lower level of induced apoptosis. Further, upon cDDP treatment, the levels of Fas, Bax and Bid remained unchanged, whereas Bcl-2 and p-Bad were reduced at late times (120 hr) after treatment. At early times, Fas ligand (fas-L) expression was significantly enhanced in sensitive compared to resistant cells and remained upregulated up to the onset of apoptosis. Thus, activation of the Fas system is critical, which is in line with the finding that in sensitive cells, caspase-8 along with caspase-9 and -3 were activated by cDDP. cDDP provoked the activation of stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) and p38 kinase dose-dependently, with significantly lower levels in ACR cells than in the sensitive parental line. cDDP induces c-Jun and AP-1 activity, as measured by a reporter gene assay, which was again attenuated in ACR cells. Time course analysis revealed that SAPK/JNK and p38 kinase activity was sustained upregulated (> 7...Continue Reading

References

Nov 24, 1995·Science·Z XiaM E Greenberg
Sep 23, 1994·Cell·C SachsenmaierH J Rahmsdorf
Jan 1, 1993·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·M Osmak, D Eljuga
Sep 27, 1996·The Journal of Biological Chemistry·P PandeyS Kharbanda
Nov 21, 1996·Nature·C E Canman, M B Kastan
Nov 15, 1996·Cell·H G WangJ C Reed
May 26, 1999·The Journal of Pathology·C A Schmitt, S W Lowe
Jul 14, 1999·FEBS Letters·I Sánchez-Pérez, R Perona
Jan 26, 2000·British Journal of Cancer·P J BealeL R Kelland
Sep 20, 2000·The Journal of Biological Chemistry·X WangN J Holbrook
May 9, 2001·Mutation Research·P C Hanawalt
Jun 19, 2001·Mutation Research·M Kartalou, J M Essigmann
Jul 12, 2001·The Journal of Biological Chemistry·G Q WangH Rabinowich
Sep 12, 2001·The International Journal of Biochemistry & Cell Biology·R K Barr, M A Bogoyevitch
Sep 25, 2001·Trends in Cell Biology·A K Pearce, T C Humphrey
Oct 23, 2001·Methods in Enzymology·J Perry Hall, Roger J Davis
Dec 26, 2001·Chemical Reviews·E R Jamieson, S J Lippard
Apr 12, 2002·Oncogene·Konrad HochedlingerKanaga Sabapathy

❮ Previous
Next ❯

Citations

Oct 1, 2005·Cancer Chemotherapy and Pharmacology·Monica LupiPaolo Ubezio
Dec 24, 2009·Nature Reviews. Cancer·Pablo Lopez-BergamiZe'ev Ronai
Sep 6, 2011·Oncogene·L GalluzziG Kroemer
Jan 15, 2009·The Journal of Biological Chemistry·Karoline LeonhardtDominik Huster
Mar 23, 2011·Biochemistry. Biokhimii︠a︡·V A Efimov, S V Fedyunin
Jun 28, 2011·Arhiv za higijenu rada i toksikologiju·Ksenija DurgoJasna Franekić
May 31, 2014·Cell Death & Disease·L GalluzziG Kroemer
Sep 15, 2015·BioMed Research International·Yanxia SuiJuan Ren
Dec 3, 2015·Chemical Research in Toxicology·Aurimas StulpinasAudronė Valerija Kalvelytė
May 10, 2011·European Journal of Medicinal Chemistry·Tamara Cimbora-ZovkoMaja Osmak
Nov 26, 2010·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Na WangFukang Xie
Jul 22, 2010·Biochimica Et Biophysica Acta·Beate KöberleBernd Kaina
Dec 19, 2015·Nature Reviews. Cancer·Wynand P RoosBernd Kaina
Sep 27, 2015·Journal of Inorganic Biochemistry·Jure VajsJanez Košmrlj
Oct 11, 2008·Mutation Research·Luís F Z BatistaCarlos F M Menck
Mar 6, 2007·Critical Reviews in Oncology/hematology·David J Stewart
Jun 8, 2007·Pediatric Blood & Cancer·Mimi TajbakhshRichard B Lock
Aug 14, 2012·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Cai-Guo YeChi-Hin Cho
Feb 22, 2005·Biochemical and Biophysical Research Communications·Shigenori HoshinoIchiro Kawase
Aug 11, 2006·Trends in Molecular Medicine·Wynand P Roos, Bernd Kaina
Oct 20, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Alan Richardson, Stan B Kaye
Oct 30, 2012·Neurotoxicology·Giada SantinMaria Grazia Bottone
Nov 14, 2006·Biochemical Pharmacology·Jochen ZisowskyUlrich Jaehde
Feb 15, 2015·The International Journal of Biochemistry & Cell Biology·Snehal M GaikwadPritha Ray

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis